^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
10/06/2021
Excerpt:
Myelodysplastic…Atypical chronic myeloid leukemia…Frequent mutations: SETBP1, ETNK1; Treatment: Consider HMA and/or ruxolitinib…